Lichen International Limited Fundamental Analysis (NASDAQ: LICN)
Lichen International Limited Fundamental Analysis (NASDAQ: LICN)
Lichen International Limited (NASDAQ: LICN) shows weak financial fundamentals with a PE ratio of -0.62, profit margin of -1.18%, and ROE of -36.76%. The company generates $0.0B in annual revenue with weak year-over-year growth of -40.89%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -137.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze LICN's fundamental strength across five key dimensions:
Efficiency Score
WeakLICN struggles to generate sufficient returns from assets.
Valuation Score
ExcellentLICN trades at attractive valuation levels.
Growth Score
WeakLICN faces weak or negative growth trends.
Financial Health Score
ExcellentLICN maintains a strong and stable balance sheet.
Profitability Score
WeakLICN struggles to sustain strong margins.
Key Financial Metrics
Is LICN Expensive or Cheap?
P/E Ratio
LICN trades at -0.62 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, LICN's PEG of -0.01 indicates potential undervaluation.
Price to Book
The market values Lichen International Limited at 0.25 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -2.65 times EBITDA. This is generally considered low.
How Well Does LICN Make Money?
Net Profit Margin
For every $100 in sales, Lichen International Limited keeps $-1.18 as profit after all expenses.
Operating Margin
Core operations generate -87.13 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-36.76 in profit for every $100 of shareholder equity.
ROA
Lichen International Limited generates $-37.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Lichen International Limited generates limited operating cash flow of $-21.66M, signaling weaker underlying cash strength.
Free Cash Flow
Lichen International Limited generates weak or negative free cash flow of $-15.89M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.98 in free cash annually.
FCF Yield
LICN converts -1.07% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-0.62
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.01
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.25
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.73
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.005
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.81
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.37
vs 25 benchmark
ROA
Return on assets percentage
-0.37
vs 25 benchmark
ROCE
Return on capital employed
-0.29
vs 25 benchmark
How LICN Stacks Against Its Sector Peers
| Metric | LICN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -0.62 | 27.27 | Better (Cheaper) |
| ROE | -36.76% | 1166.00% | Weak |
| Net Margin | -117.70% | 43.00% | Weak |
| Debt/Equity | 0.00 | 0.76 | Strong (Low Leverage) |
| Current Ratio | 5.81 | 22.04 | Strong Liquidity |
| ROA | -37.00% | -1350484.00% (disorted) | Weak |
LICN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Lichen International Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
333.48%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
-1958.56%
Industry Style: Cyclical, Value, Infrastructure
DecliningFCF CAGR
-1259.01%
Industry Style: Cyclical, Value, Infrastructure
Declining